NeuroBo Pharmaceuticals Inc. (NRBO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

NeuroBo Pharmaceuticals I...

NASDAQ: NRBO · Real-Time Price · USD
2.36
null (null%)
At close: Nov 27, 2024, 10:00 PM

NeuroBo Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
16.02M 22.43M 33.36M 16.39M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
21K 21K n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
55K 64K 168K n/a
Total Current Assets
16.07M 22.51M 33.53M 16.58M
Property-Plant & Equipment
167K 248K 2K 215K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
188K 269K 2K 215K
Total Assets
16.26M 22.78M 33.53M 16.8M
Account Payables
3.88M 821K 708K 830K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
78K 67K n/a 26K
Other Current Liabilities
8.19M 4.89M 10.98M 899K
Total Current Liabilities
8.27M 5.96M 11.78M 2.16M
Long-Term Debt
58K n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
58K 136K 708K 45K
Total Liabilities
8.33M 6.1M 11.78M 2.2M
Total Debt
136K 203K n/a 71K
Book Value
7.93M 16.68M 21.75M 14.6M
Book Value Per Share
0.10 3.29 67.61 151.37
Common Stock
9K 5K 25K 27K
Retained Earnings
-135.86M -108.27M -95.8M -81.83M
Comprehensive Income
n/a 0.00 0.00 4K
Shareholders Equity
7.93M 16.68M 21.75M 14.6M
Total Investments
n/a n/a n/a n/a